An Audit of the Use of Cabazitaxel for the Treatment of Metastatic Castrate Resistant Prostate Cancer (mCRPC) Compared with Previous Experience with ECarboF (Epirubicin, Carboplatin and 5-fluorouracil) in a Single Institution

Al-Bakir M.; Williams S.; Davda R.; Mascoll J.; Lynch C.; Mitra A.; Payne H.; Dickson J.; Harland S.; Lopes A.; McGovern U.; Chau N. -M.; Linch M.

首页> 外文期刊>Clinical oncology >An Audit of the Use of Cabazitaxel for the Treatment of Metastatic Castrate Resistant Prostate Cancer (mCRPC) Compared with Previous Experience with ECarboF (Epirubicin, Carboplatin and 5-fluorouracil) in a Single Institution

【24h】

An Audit of the Use of Cabazitaxel for the Treatment of Metastatic Castrate Resistant Prostate Cancer (mCRPC) Compared with Previous Experience with ECarboF (Epirubicin, Carboplatin and 5-fluorouracil) in a Single Institution

机译：与单一机构中ECarboF（表柔比星，卡铂和5-氟尿嘧啶）以往的经验相比，使用卡巴他赛治疗转移性去势抵抗性前列腺癌（mCRPC）的审计

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical oncology》 |2016年第5期|共1页
作者
Al-Bakir M.; Williams S.; Davda R.; Mascoll J.; Lynch C.; Mitra A.; Payne H.; Dickson J.; Harland S.; Lopes A.; McGovern U.; Chau N. -M.; Linch M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
入库时间 2022-08-18 09:34:16

相似文献

外文文献
中文文献
专利

1. An Audit of the Use of Cabazitaxel for the Treatment of Metastatic Castrate Resistant Prostate Cancer (mCRPC) Compared with Previous Experience with ECarboF (Epirubicin, Carboplatin and 5-fluorouracil) in a Single Institution [J] . Al-Bakir M., Williams S., Davda R., Clinical oncology . 2016,第5期

机译：与单一机构中ECarboF（表柔比星，卡铂和5-氟尿嘧啶）以往的经验相比，使用卡巴他赛治疗转移性去势抵抗性前列腺癌（mCRPC）的审计
2. Tolerability of cabazitaxel in patients with metastatic castration-resistant prostate cancer progressing after docetaxel and abiraterone acetate: a single-institution experience [J] . Francini Edoardo, Fiaschi Anna I., Petrioli Roberto, Anti-cancer drugs . 2015,第8期

机译：卡巴他赛对多西他赛和醋酸阿比特龙治疗后转移性去势抵抗性前列腺癌患者的耐受性：单机构经验
3. Docetaxel in the treatment of metastatic castration-resistant prostate cancer (mCRPC): An observational study in a single institution [J] . SchallierD., DecosterL., BraeckmanJ., Anticancer Research: International Journal of Cancer Research and Treatment . 2012,第2期

机译：多西他赛治疗转移性去势抵抗性前列腺癌（mCRPC）：单个机构的观察性研究
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Single institution long-term efficacy and safety analysis of abiraterone acetate (AA) in the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) in a named patient programme (NPP) [O] . Ana Fröbe, Jure Murgić, Stefan Rauh 2016

机译：在指定的患者计划（NPP）中醋酸阿比特龙（AA）在治疗转移性去势抵抗性前列腺癌（mCRPC）患者中的单一机构长期疗效和安全性分析
7. PCN101 COST EFFECTIVENESS ANALYSIS COMPARING ENZALUTAMIDE, ABIRATERONE PLUS PREDNISONE AND CABAZITAXEL PLUS PREDINSONE FOR THE TREATMENT OF VISCERAL METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) POST DOCETAXEL FAILURE [O] . Y. Barqawi, M. Borrego, M. Roberts, 2019

机译：PCN101成本效益分析比较烯醇胺，Abiraatorone Plus泼尼松和Cabazitaxel加上预先治疗内脏转移性阉割抗性前列腺癌（MCRPC）后的多紫杉醇失败

An Audit of the Use of Cabazitaxel for the Treatment of Metastatic Castrate Resistant Prostate Cancer (mCRPC) Compared with Previous Experience with ECarboF (Epirubicin, Carboplatin and 5-fluorouracil) in a Single Institution

著录项

相似文献

相关主题

期刊订阅